Your browser doesn't support javascript.
loading
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study.
You, Benoit; Purdy, Christopher; Copeland, Larry J; Swisher, Elizabeth M; Bookman, Michael A; Fleming, Gini; Coleman, Robert; Randall, Leslie M; Tewari, Krishnansu S; Monk, Bradley J; Mannel, Robert S; Walker, Joan L; Cappuccini, Fabio; Cohn, David; Muzaffar, Mahvish; Mutch, David; Wahner-Hendrickson, Andrea; Martin, Lainie; Colomban, Olivier; Burger, Robert A.
Afiliação
  • You B; Université Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France GINECO, Paris, France.
  • Purdy C; Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), CITOHL, GINECO-GINEGEPS, Lyon, France.
  • Copeland LJ; Clinical Trial Development Division, Biostatistics and Bioinformatics Department, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Swisher EM; The Ohio State University, James Cancer Hospital, Columbus, OH.
  • Bookman MA; Division of Gynecologic Oncology, Department of Ob/Gyn, University of Washington, Seattle, WA.
  • Fleming G; Director, Gynecologic Oncology Therapeutics, Kaiser Permanente Northern California, San Francisco, CA.
  • Coleman R; Hematology and Oncology, The University of Chicago Medicine, Chicago, IL.
  • Randall LM; Chief Scientific Officer, US Oncology Research, The Woodlands, TX.
  • Tewari KS; Division of Gynecologic Oncology, Virginia Commonwealth University, School of Medicine, Richmond, VA.
  • Monk BJ; UC Irvine Medical Center, Orange, CA.
  • Mannel RS; HonorHealth Research Institute, University of Arizona, Creighton University, Phoenix, AZ.
  • Walker JL; The University of Oklahoma, Oklahoma City, OK.
  • Cappuccini F; The University of Oklahoma, Oklahoma City, OK.
  • Cohn D; UC Irvine Medical Center, Orange, CA.
  • Muzaffar M; The Ohio State University, James Cancer Hospital, Columbus, OH.
  • Mutch D; Internal Medicine, East Carolina University, Greenville, NC.
  • Wahner-Hendrickson A; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO.
  • Martin L; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
  • Colomban O; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA.
  • Burger RA; Mersana Therapeutics, Cambridge, MA.
J Clin Oncol ; 40(34): 3965-3974, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36252167
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Paclitaxel Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Paclitaxel Idioma: En Ano de publicação: 2022 Tipo de documento: Article